| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 1,552 | 1,088 | 588 | 1,312 |
| Net income from continuing operations | 1,552 | - | - | - |
| Depreciation of property, plant, and equipment | 213 | 138 | 66 | 203 |
| Amortization of intangible assets | 219 | 146 | 70 | 237 |
| Gain on fair value remeasurement of contingent consideration | - | - | - | -19 |
| Gain on remeasurement of nihon medi-physics equity method investment | 97 | 97 | 97 | - |
| Net periodic postretirement benefit plan (income) expense | -208 | -138 | -70 | -271 |
| Postretirement plan contributions | 260 | 182 | 98 | 257 |
| Share-based compensation | 94 | 56 | 22 | 92 |
| Provision for income taxes | 395 | 216 | 104 | 435 |
| Cash paid during the year for income taxes | 353 | 270 | 91 | 375 |
| Receivables | 6 | -185 | -81 | -83 |
| Due from related parties | - | - | - | -24 |
| Inventories | 217 | 188 | 154 | 157 |
| Contract and other deferred assets | 111 | 48 | -52 | 33 |
| Accounts payable | -119 | -113 | 146 | 3 |
| Due to related parties | - | - | - | -72 |
| Contract liabilities | 1 | -23 | -68 | -25 |
| Current compensation and benefits | -29 | -207 | -200 | -97 |
| All other operating activities net | -136 | -218 | -101 | -41 |
| Cash from (used for) operating activities | - | 344 | 250 | - |
| Cash from (used for) operating activities continuing operations | 937 | - | - | 1,042 |
| Additions to property, plant and equipment and internal-use software | 348 | 238 | 152 | 299 |
| Dispositions of property, plant, and equipment | - | - | - | 0 |
| Purchases of businesses, net of cash acquired | 279 | 279 | 269 | 259 |
| Purchases of investments | 82 | 28 | 20 | 33 |
| All other investing activities net | 69 | 84 | -34 | 83 |
| Cash from (used for) investing activities continuing operations | -778 | -630 | -407 | -674 |
| Net increase (decrease) in borrowings (maturities of 90 days or less) | - | 1 | 1 | 0 |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | 1,494 | 1,493 | 0 | 994 |
| Repayments and other reductions (maturities longer than 90 days) | 265 | 261 | 257 | 162 |
| Dividends paid to stockholders | 48 | 32 | 16 | 41 |
| Redemption of noncontrolling interests | - | - | - | 0 |
| Net transfers (to) from ge | - | - | - | 0 |
| Repurchase of common stock | 200 | 100 | - | - |
| Proceeds from stock issued under employee benefit plans | 25 | 21 | 20 | 31 |
| Taxes paid related to net share settlement of equity awards | 41 | 33 | 28 | 90 |
| All other financing activities net | -56 | -15 | -6 | -28 |
| Cash from (used for) financing activities continuing operations | 910 | 1,075 | -286 | 704 |
| Cash from (used for) operating activities discontinued operations | 0 | - | - | -4 |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | 68 | 84 | 27 | -2 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 1,137 | 873 | -416 | 1,066 |
| Cash and cash equivalents at beginning of period | 2,893 | 2,893 | 2,893 | 2,506 |
| Cash and cash equivalents at end of period | 4,030 | 3,766 | 2,476 | 3,572 |
GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC)